Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22451 | 324 | 37.5 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1680 | 6226 | MARFAN SYNDROME//FIBRILLIN//LYSYL OXIDASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FIBULIN 1 | Author keyword | 28 | 69% | 7% | 24 |
2 | EFEMP1 | Author keyword | 18 | 83% | 3% | 10 |
3 | FIBULIN 3 | Author keyword | 17 | 75% | 4% | 12 |
4 | FIBULIN | Author keyword | 14 | 51% | 6% | 19 |
5 | FIBULIN 5 | Author keyword | 12 | 42% | 7% | 22 |
6 | FIBULIN 2 | Author keyword | 12 | 86% | 2% | 6 |
7 | MALATTIA LEVENTINESE | Author keyword | 10 | 63% | 3% | 10 |
8 | FIBULINS | Author keyword | 7 | 67% | 2% | 6 |
9 | FBLN1 | Author keyword | 6 | 80% | 1% | 4 |
10 | PROGRAM CELL STRUCT DEV | Address | 6 | 100% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FIBULIN 1 | 28 | 69% | 7% | 24 | Search FIBULIN+1 | Search FIBULIN+1 |
2 | EFEMP1 | 18 | 83% | 3% | 10 | Search EFEMP1 | Search EFEMP1 |
3 | FIBULIN 3 | 17 | 75% | 4% | 12 | Search FIBULIN+3 | Search FIBULIN+3 |
4 | FIBULIN | 14 | 51% | 6% | 19 | Search FIBULIN | Search FIBULIN |
5 | FIBULIN 5 | 12 | 42% | 7% | 22 | Search FIBULIN+5 | Search FIBULIN+5 |
6 | FIBULIN 2 | 12 | 86% | 2% | 6 | Search FIBULIN+2 | Search FIBULIN+2 |
7 | MALATTIA LEVENTINESE | 10 | 63% | 3% | 10 | Search MALATTIA+LEVENTINESE | Search MALATTIA+LEVENTINESE |
8 | FIBULINS | 7 | 67% | 2% | 6 | Search FIBULINS | Search FIBULINS |
9 | FBLN1 | 6 | 80% | 1% | 4 | Search FBLN1 | Search FBLN1 |
10 | AUTOSOMAL DOMINANT DRUSEN | 4 | 75% | 1% | 3 | Search AUTOSOMAL+DOMINANT+DRUSEN | Search AUTOSOMAL+DOMINANT+DRUSEN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABERRANT ACCUMULATION | 27 | 83% | 5% | 15 |
2 | MALATTIA LEVENTINESE | 20 | 48% | 9% | 30 |
3 | EFEMP1 | 19 | 74% | 4% | 14 |
4 | HONEYCOMB RETINAL DYSTROPHY | 14 | 55% | 5% | 17 |
5 | EFEMP1 MUTATION | 9 | 83% | 2% | 5 |
6 | FIBULIN 1 | 8 | 48% | 4% | 12 |
7 | RECESSIVE CUTIS LAXA | 5 | 54% | 2% | 7 |
8 | ELASTIC FIBER FORMATION | 5 | 43% | 3% | 9 |
9 | FIBULIN 3 | 4 | 67% | 1% | 4 |
10 | CUTIS LAXA | 3 | 13% | 7% | 24 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Fibulins: Multiple roles in matrix structures and tissue functions | 2009 | 76 | 102 | 66% |
Fibulins: A versatile family of extracellular matrix proteins | 2003 | 200 | 87 | 68% |
Fibulins and cancer: friend or foe? | 2005 | 71 | 35 | 89% |
Fibulins: physiological and disease perspectives | 2003 | 161 | 58 | 62% |
Specific structure and unique function define the hemicentin | 2013 | 4 | 20 | 80% |
Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies | 2014 | 6 | 84 | 33% |
Unraveling the mechanism of elastic fiber assembly: The roles of short fibulins | 2010 | 34 | 98 | 41% |
The dual role of fibulins in tumorigenesis | 2012 | 10 | 82 | 68% |
Diverse functions of fibulin-5 in tumor | 2014 | 0 | 39 | 69% |
Fibulins and Their Role in Cardiovascular Biology and Disease | 2014 | 0 | 80 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM CELL STRUCT DEV | 6 | 100% | 1.2% | 4 |
2 | IN IDUALIZED MED ARTERIAL DIS | 2 | 36% | 1.2% | 4 |
3 | ADV COSMET S | 1 | 50% | 0.6% | 2 |
4 | GEN ONCOL B BREAST UNIT | 1 | 100% | 0.6% | 2 |
5 | IMMUNO MICROENVIRONM DISEDUC MINIST | 1 | 100% | 0.6% | 2 |
6 | CARDIOVASC UNIT CARDIOL | 1 | 50% | 0.3% | 1 |
7 | DAEJEON KRIBB FHCRC ABORAT | 1 | 50% | 0.3% | 1 |
8 | ENGN BIOCHIP | 1 | 50% | 0.3% | 1 |
9 | EPI GENOME | 1 | 50% | 0.3% | 1 |
10 | JEROME H HOLLAND BIOCHEM | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216019 | CUTIS LAXA//MID DERMAL ELASTOLYSIS//ANNULAR ELASTOLYTIC GIANT CELL GRANULOMA |
2 | 0.0000137050 | MARFAN SYNDROME//FIBRILLIN//FBN1 |
3 | 0.0000074192 | LTBP//ALPHA V BETA 6//INTEGRIN ALPHAVBETA6 |
4 | 0.0000073969 | AGE RELATED MACULAR DEGENERATION//DRUSEN//ARMS2 |
5 | 0.0000072586 | LIPOID PROTEINOSIS//HYALINOSIS CUTIS ET MUCOSAE//EXTRACELLULAR MATRIX PROTEIN 1 |
6 | 0.0000068324 | LYSYL OXIDASE//LOXL2//LYSYL OXIDASE LIKE 2 |
7 | 0.0000066136 | BEST VITELLIFORM MACULAR DYSTROPHY//VMD2//BEST1 |
8 | 0.0000056918 | ABCA4//STARGARDT DISEASE//A2E |
9 | 0.0000055147 | CTRP3//CTRP 3//CTRP5 |
10 | 0.0000053569 | ISODESMOSINE//ELASTIN LAMININ RECEPTOR//DESMOSINE |